A pan-cancer analysis demonstrated the consistent upregulation of NXPH4 across various DSCs, suggesting its diagnostic potential in cholangiocarcinoma, esophageal cancer, liver cancer, and gastric cancer (Fig. S1). The gene discussed is NXPH4; the disease is liver cancer.